Add articles to your saved list and come back to them any time. The only one of its kind in Victoria, this Chinese honey locust tree is believed to be about 180 years old. It was possibly planted by a ...
Crews are driving test piles into the Patapsco River as part of the Francis Scott Key Bridge replacement project in Baltimore As the last remaining spans of Baltimore’s original Francis Scott Key ...
Shares of Transformers & Rectifiers India (TRIL), a leading transformer manufacturer, were locked in a 20% lower circuit in Monday's session, November 10, falling to the lowest level since October ...
Shares of Transformers and Rectifiers (India) Ltd (TARIL) slumped 20 per cent in Monday's trade to hit their lower price band of Rs 314.20, following weak quarterly results and a World Bank debarment.
Officials provided an up-close look at the progress being made at the site of the Key Bridge rebuild on Wednesday. The test pile program involves massive cranes, a gigantic hammer and 12 220-foot ...
THEY HAVE TWO OF THE LARGEST ROTATING CRANES ON THE EAST COAST RIGHT HERE FOR THIS PROJECT AT THE MOMENT. AND THAT’S BECAUSE OF THE SHEER SIZE OF THE PILES THAT THEY’RE DRIVING IN THIS TEST. THE 200FT ...
There are two floating construction sites set up inside the gap where Baltimore’s Key Bridge used to stand. And as crews continue to dismantle the old bridge — which is about halfway done — test ...
Officials provided an up-close look at the progress being made at the site of the Key Bridge rebuild on Wednesday. The test pile program involves massive cranes, a gigantic hammer and 12 220-foot ...
Driverless vehicles will operate on the Hong Kong-Zhuhai-Macau Bridge and in Kai Tak in November after transport authorities issued two more licences. The Transport Department said on Thursday that ...
President Trump told reporters Monday he underwent an MRI and a cognitive test during his “secondary” physical at Walter Reed earlier this year. The president did not detail the reason for the MRI, ...
BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA ...